Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 19 | Rare Historical Photos

UK households hit by rising cost of living; Omicron lifts US jobless claims to three-month high – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

FTSE 100 Live: Unilever shares rise as Glaxo interest cools, China cuts rates, Nasdaq in correction territory

The Nasdaq’s slide into “correction” territory after falling 10% since November today failed to unsettle the FTSE 100 index.

Evening Standard

Unilever won't up £50bn offer for GSK-Pfizer unit

LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Marmite maker Unilever urged to focus on health by shareholder group after difficult week

The group sold PG Tips and Lipton to CVC Partners for £3.8bn towards the end of 2021

Birmingham Post

Big questions for Unilever board after GSK pursuit ends

Delivering a minor heart attack to the share price, however temporarily, is not a good look

The Guardian - UK

Unilever will not increase £50bn offer for GSK consumer arm

Company says data shared by GSK suggests ‘fundamental value’ of business no higher than offer

The Guardian - UK

Unilever won't top $68B bid for GSK consumer healthcare unit

Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Unilever vows not to increase GSK bid

Unilever has effectively ruled out a fourth takeover approach for GlaxoSmithKline’s consumer healthcare business after vowing not to increase its offer.

Evening Standard

Little ingenuity needed to spot the weakness of THG

The value of the e-commerce firm’s ‘end-to-end technology solutions’ doesn’t seem clear – no wonder investors went cold

The Guardian - UK

Unilever ‘could lose credit rating’ with purchase of GSK consumer arm

Deal could swell Unilever’s debt pile, says ratings agency Fitch

The Guardian - UK

Unilever’s bid for GSK consumables isn’t quite the shocker it seems

This could be a long campaign and, despite all the difficulties, there is a logic to the proposal

The Guardian - UK

Unilever punished by City for failed £50bn tilt at GSK

A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline.

Evening Standard

Unilever to expand health and beauty business after failed GSK approach

Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed

The Guardian - UK

FTSE 100 Live: Unilever latest on Glaxo swoop, Credit Suisse boss quits, China GDP

Shares in Marmite maker Unilever are sharply lower after it made an audacious swoop for GlaxoSmithKline's consumer healthcare arm.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

India’s Modi calls for global approach to tackle crypto; FTSE 100 at two-year high – as it happened

Rolling coverage of the latest economic and financial news

Fortune

PPG Drops Its Bid for Akzo After Running Into a Dutch Wall

Managers, unions, judges and politicians all said 'no'

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Associated British Foods

62 stories

GlaxoSmithKline

37 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.